Athira Pharma Statistics Share Statistics Athira Pharma has 3.94M
shares outstanding. The number of shares has increased by 1.57%
in one year.
Shares Outstanding 3.94M Shares Change (YoY) 1.57% Shares Change (QoQ) 0% Owned by Institutions (%) 44.99% Shares Floating 3.38M Failed to Deliver (FTD) Shares 1,511 FTD / Avg. Volume 5.69%
Short Selling Information The latest short interest is 961.27K, so 24.37% of the outstanding
shares have been sold short.
Short Interest 961.27K Short % of Shares Out 24.37% Short % of Float 28.98% Short Ratio (days to cover) 4.12
Valuation Ratios The PE ratio is -0.23 and the forward
PE ratio is -0.72.
Athira Pharma's PEG ratio is
0.01.
PE Ratio -0.23 Forward PE -0.72 PS Ratio 0 Forward PS 1.1 PB Ratio 0.5 P/FCF Ratio -0.23 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Athira Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.18,
with a Debt / Equity ratio of 0.03.
Current Ratio 4.18 Quick Ratio 4.18 Debt / Equity 0.03 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.73M Employee Count 26 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -13.51% in the
last 52 weeks. The beta is 3.02, so Athira Pharma's
price volatility has been higher than the market average.
Beta 3.02 52-Week Price Change -13.51% 50-Day Moving Average 3.96 200-Day Moving Average 3.88 Relative Strength Index (RSI) 48.93 Average Volume (20 Days) 26,547
Income Statement
Revenue n/a Gross Profit -970K Operating Income -100.9M Net Income -96.94M EBITDA -95.97M EBIT -96.94M Earnings Per Share (EPS) -25.2
Full Income Statement Balance Sheet The company has 48.44M in cash and 1.22M in
debt, giving a net cash position of 47.22M.
Cash & Cash Equivalents 48.44M Total Debt 1.22M Net Cash 47.22M Retained Earnings -406.15M Total Assets 35.55M Working Capital 29.24M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -97.17M
and capital expenditures -33K, giving a free cash flow of -97.2M.
Operating Cash Flow -97.17M Capital Expenditures -33K Free Cash Flow -97.2M FCF Per Share -25.26
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ATHA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ATHA is $5,
which is 30.2% higher than the current price. The consensus rating is "Hold".
Price Target $5 Price Target Difference 30.2% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 18, 2025. It was a
backward
split with a ratio of 1:10.
Last Split Date Sep 18, 2025 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -18.39 Piotroski F-Score 2
